NCT05728944: Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
- State
- Completed
- Phase
- Phase 3
- People
- 229 taking part
- Started
- 6 Mar 2023
- Primary completion
- 14 Dec 2023
- Arms
- Vehicle Ophthalmic Solution dosed bilaterally
- Results
- Posted on the registry
- 15 Feb 2023: Trial registered
- 6 Mar 2023: Trial started
- 24 Jan 2024: Trial completed
- 25 Feb 2026: Trial results posted